You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

EnteroBiotix announces partnership with Imperial College London

EnteroBiotix (EBX) – a microbiome therapeutics company – has announced a partnership with Imperial College London (Imperial) to develop microbiome R&D in patients suffering from blood cancer.